Quadrant Capital Group’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.71M | Sell |
|
|||||
|
2025
Q2 | $2.38M | Buy |
|
|||||
|
2025
Q1 | $2.2M | Buy |
|
|||||
|
2024
Q4 | $537K | Sell |
|
|||||
|
2024
Q3 | $665K | Buy |
|
|||||
|
2024
Q2 | $595K | Sell |
|
|||||
|
2024
Q1 | $743K | Buy |
|
|||||
|
2023
Q4 | $620K | Sell |
|
|||||
|
2023
Q3 | $608K | Buy |
|
|||||
|
2023
Q2 | $497K | Sell |
|
|||||
|
2023
Q1 | $523K | Buy |
|
|||||
|
2022
Q4 | $494K | Buy |
|
|||||
|
2022
Q3 | $110K | Sell |
|
|||||
|
2022
Q2 | $517K | Buy |
|
|||||
|
2022
Q1 | $395K | Buy |
|
|||||
|
2021
Q4 | $371K | Sell |
|
|||||
|
2021
Q3 | $340K | Buy |
|
|||||
|
2021
Q2 | $300K | Buy |
|
|||||
|
2021
Q1 | $233K | Buy |
|
|||||
|
2020
Q4 | $174K | Sell |
|
|||||
|
2020
Q3 | $269K | Buy |
|
|||||
|
2020
Q2 | $204K | Sell |
|
|||||
|
2020
Q1 | $1.25M | Buy |
|
|||||
|
2019
Q4 | $1.41M | Buy |
|
|||||
|
2019
Q3 | $1.19M | Buy |
|
|||||
|
2019
Q2 | $1.09M | Buy |
|
|||||
|
2019
Q1 | $910K | Buy |
|
|||||
|
2018
Q4 | $649K | Buy |
|
|||||
|
2018
Q3 | $187K | Sell |
|
|||||
|
2018
Q2 | $240K | Buy |
|
|||||
|
2018
Q1 | $158K | Buy |
|
|||||
|
2017
Q4 | $71K | Sell |
|
|||||
|
2017
Q3 | $171K | Buy |
|
|||||
|
2017
Q2 | $162K | Buy |
|
|||||
|
2017
Q1 | $170K | Buy |
|
|||||
|
2016
Q4 | $63K | Sell |
|
|||||
|
2016
Q3 | $122K | Buy |
|
|||||
|
2016
Q2 | $111K | Buy |
|
|||||
|
2016
Q1 | $99K | Buy |
|
|||||
|
2015
Q4 | $48K | Buy |
|
|||||
|
2015
Q3 | $37K | Buy |
|
|||||
|
2015
Q2 | $41K | Buy |
|